ORPHAZYME TO PRESENT AT BIOCENTURY 25TH ANNUAL NEWSMAKERS IN THE BIOTECH INDUSTRY

Copenhagen, September 6, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Anders Hinsby, Chief Executive Officer at Orphazyme, will be presenting at the BioCentury 25th Annual NewsMakers in the Biotech Industry in New York, USA on September 7, 2018 at 9.30 AM EDT.